Skip to main content
NeuronFeed

Generate:Biomedicines vs Owkin

Which Healthcare AI tool is better in 2026?

Generate:Biomedicines

Generative AI for programmable protein therapeutics

$700M

Owkin

Pioneering biological artificial superintelligence to automate R&D and connect research directly to patient care.

$354M

Side-by-side

Verdict

Generate:Biomedicines is the more established option (raised $700M); pricing is comparable on both sides.

Metric Generate:Biomedicines Owkin
Taglinei Generative AI for programmable protein therapeutics Pioneering biological artificial superintelligence to automate R&D and connect research directly to patient care.
Foundedi 2018 2016🏆
HQi Somerville, United States FR
Employeesi
Neuron scorei 77🏆 72
Total fundingi $700M🏆 $354M
Latest roundi Series C · Sep 2023 Series B · Nov 2021
Valuationi $1B🏆
Cheapest paid plani Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed K Pro License · Contact sales
Pricing summaryi Custom 1 published plans
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Generate:Biomedicines and Owkin.

Capability Generate:Biomedicines Owkin
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Generate:Biomedicines

  • Has raised more capital ($700M vs $354M)
  • Higher Neuron score (77 vs 72)
  • Newer company (2018)

🔵 Strengths of Owkin

  • More mature (2016)

Which should you choose?

Choose Owkin if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Generate:Biomedicines if you want the most established option — it has raised $700M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Generate:Biomedicines vs Owkin — which is better?

It depends on your priority. Generate:Biomedicines has raised more capital and is the more established option; Owkin has broader feature depth. See the side-by-side table above.

Is Generate:Biomedicines cheaper than Owkin?

No — Owkin's cheapest paid plan is Enterprise · Contact sales, while Generate:Biomedicines's is Custom.

Do Generate:Biomedicines and Owkin offer free plans?

Generate:Biomedicines: Paid only. Owkin: Paid only.

Contextual paths to related AI startups, deals and rankings.